These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23958393)

  • 21. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.
    Brannan JD; Anderson SD; Gomes K; King GG; Chan HK; Seale JP
    Am J Respir Crit Care Med; 2001 May; 163(6):1420-5. PubMed ID: 11371412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
    Nelson KA; Smith SR; Trinkaus K; Jaffe DM
    Pediatr Emerg Care; 2008 Jan; 24(1):21-7. PubMed ID: 18165796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial asthma accompanied with allergic rhinitis: a randomized, double blind, placebo-controlled study.
    Li J; Luo DF; Li SY; Sun BQ; Zhong NS
    Chin Med J (Engl); 2005 Oct; 118(19):1595-603. PubMed ID: 16232343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: a pilot study.
    Olszowiec-Chlebna M; Majak P; Brzozowska A; Bobrowska-Korzeniowska M; Jerzynska J; Stelmach I
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e687-90. PubMed ID: 20202147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of home characteristics in children with allergic rhinitis and asthma.
    Salehi M; Moradi S; Chavoshzadeh Z; Gorji FA; Khoramrooz Z; Rezaei N
    Acta Clin Croat; 2011 Jun; 50(2):225-7. PubMed ID: 22263386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
    Meltzer EO; Gillman SA
    Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
    Kruszewski J; Kłos K; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. House-dust mite nasal provocation: a diagnostic tool in perennial rhinitis.
    Chusakul S; Phannaso C; Sangsarsri S; Aeumjaturapat S; Snidvongs K
    Am J Rhinol Allergy; 2010; 24(2):133-6. PubMed ID: 20338112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of topical vapocoolant spray on skin test wheal, flare, and pain responses.
    Waibel KH; Katial RK
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):149-53. PubMed ID: 16136764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial.
    Todi VK; Lodha R; Kabra SK
    Arch Dis Child; 2010 Jul; 95(7):540-3. PubMed ID: 20522464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis.
    Amirav I; Luder AS; Kruger N; Borovitch Y; Babai I; Miron D; Zuker M; Tal G; Mandelberg A
    Pediatrics; 2008 Dec; 122(6):e1249-55. PubMed ID: 18984650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
    Cingi C; Ozlugedik S
    Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin test positivity to aeroallergens in the patients with chronic urticaria without allergic respiratory disease.
    Caliskaner Z; Ozturk S; Turan M; Karaayvaz M
    J Investig Allergol Clin Immunol; 2004; 14(1):50-4. PubMed ID: 15160442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.